Artwork

Contenido proporcionado por Health Unchained Podcast. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Health Unchained Podcast o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Ep. 90: First Hospital Chain in the Metaverse - Drs. Michael Kaldasch and Ben El Idrissi (Aimedis)

51:16
 
Compartir
 

Manage episode 312850659 series 2310913
Contenido proporcionado por Health Unchained Podcast. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Health Unchained Podcast o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Dr. Michael Kaldasch (CEO Aimedis)and Dr. Ben El Idrissi (COO) of Aimedis join me to update us about some of the strategies they are taking to create a medical NFT marketplace and the first hospital chain in the metaverse. It’s important to note that Aimedis already has an app made for patients, doctors, researchers, and pharmacists that is available for download in the Play and App stores. Show Notes •Updates on Aimedis company •First hospital chain in the metaverse •Virtual Reality and augmented reality applications •NFT marketplace •Migration from Ethereum to Binance smart chain •Healthcare ecosystem interactions on the platform Related episode: https://soundcloud.com/healthunchained/ep-6-bridging-healthcare-silos-dr-michael-kaldasch-ceo-aimedis News Corner https://www.sanofi.com/en/media-room/press-releases/2021/2021-11-18-07-30-00-2336966 Sanofi, recently announced a $270 million deal with French AI/precision medicine company, Owkin. This two part deal includes a $180 million equity investment in the company as well as a $90 million discovery and development partnership that spans the next three years. The collaboration will focus on leveraging its digital clinical research platform with federated AI in four different cancers- non-small cell lung cancer, triple-negative breast cancer, mesothelioma and multiple myeloma. Listen to my episode with Owkin's Chief Product Officer on episode 81 https://soundcloud.com/healthunchained/ep-81-federated-learning-with-dlt-mathieu-galtier-cpo-owkin Health Unchained Links Website: https://healthunchained.org Telegram: t.me/healthunchained Twitter: twitter.com/Healthunchaind
  continue reading

120 episodios

Artwork
iconCompartir
 
Manage episode 312850659 series 2310913
Contenido proporcionado por Health Unchained Podcast. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Health Unchained Podcast o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Dr. Michael Kaldasch (CEO Aimedis)and Dr. Ben El Idrissi (COO) of Aimedis join me to update us about some of the strategies they are taking to create a medical NFT marketplace and the first hospital chain in the metaverse. It’s important to note that Aimedis already has an app made for patients, doctors, researchers, and pharmacists that is available for download in the Play and App stores. Show Notes •Updates on Aimedis company •First hospital chain in the metaverse •Virtual Reality and augmented reality applications •NFT marketplace •Migration from Ethereum to Binance smart chain •Healthcare ecosystem interactions on the platform Related episode: https://soundcloud.com/healthunchained/ep-6-bridging-healthcare-silos-dr-michael-kaldasch-ceo-aimedis News Corner https://www.sanofi.com/en/media-room/press-releases/2021/2021-11-18-07-30-00-2336966 Sanofi, recently announced a $270 million deal with French AI/precision medicine company, Owkin. This two part deal includes a $180 million equity investment in the company as well as a $90 million discovery and development partnership that spans the next three years. The collaboration will focus on leveraging its digital clinical research platform with federated AI in four different cancers- non-small cell lung cancer, triple-negative breast cancer, mesothelioma and multiple myeloma. Listen to my episode with Owkin's Chief Product Officer on episode 81 https://soundcloud.com/healthunchained/ep-81-federated-learning-with-dlt-mathieu-galtier-cpo-owkin Health Unchained Links Website: https://healthunchained.org Telegram: t.me/healthunchained Twitter: twitter.com/Healthunchaind
  continue reading

120 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida